Epilepsy - Global Clinical Trial Landscape (2024)
By Novotech
Epilepsy is a chronic neurological condition characterised by recurring seizures affecting approximately 46 million people globally. An increase in drug-resistant epilepsy cases has triggered the need for innovative treatments with ongoing research offering promising opportunities.
In this free paper, discover how cutting-edge progress in epilepsy research is being made through Novotech CRO's in-depth disease analysis. Gain insights into novel therapeutic approaches, clinical trials, and future innovations shaping the future of epilepsy care.